Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyle A Davis

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
The Annals of Pharmacotherapy|April 10, 2015
Direct-acting oral anticoagulants as emerging treatment options for heparin-induced thrombocytopeniaMarta A Miyares, Kyle A Davis
European Journal of Haematology|July 4, 2017
Direct acting oral anticoagulants for the treatment of suspected heparin-induced thrombocytopeniaKyle A Davis, Daphne O Davis
Journal of Pharmacy Practice|August 15, 2017
Evaluation of Direct-Acting Oral Anticoagulant Use in Patients With CancerDaphne O Davis, Kyle A Davis
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 29, 2014
Lomitapide: A novel agent for the treatment of homozygous familial hypercholesterolemiaKyle A Davis, Marta A Miyares
P & T : a Peer-Reviewed Journal for Formulary Management|January 7, 2014
Serelaxin, a 'breakthrough' investigational intravenous agent for acute heart failureMarta A Miyares, Kyle A Davis
The Annals of Pharmacotherapy|October 26, 2020
Direct Oral Anticoagulants in Select Patients With Hypercoagulable DisordersSara M Valanejad, Kyle A Davis
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|September 20, 2015
Dual antiplatelet therapy with clopidogrel and aspirin after ischemic stroke: A review of the evidenceKyle A Davis, Marta A Miyares, Eric Dietrich
Journal of Thrombosis and Thrombolysis|January 10, 2020
Direct oral anticoagulants and warfarin in patients with cirrhosis: a comparison of outcomesKyle A Davis, Joel Joseph, Sarah A Nisly
The Annals of Pharmacotherapy|March 7, 2020
Outcomes Associated With Resuming Direct Oral Anticoagulant Therapy Following Admission for a Gastrointestinal BleedSara M Valanejad, Kyle A Davis, Sarah A Nisly
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|February 9, 2022
Adherence to goal-directed therapy for patients with cirrhosis hospitalized with spontaneous bacterial peritonitisChrysten M Eberhard, Kyle A Davis, Sarah A Nisly
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
The Annals of Pharmacotherapy|April 10, 2015
Direct-acting oral anticoagulants as emerging treatment options for heparin-induced thrombocytopeniaMarta A Miyares, Kyle A Davis
European Journal of Haematology|July 4, 2017
Direct acting oral anticoagulants for the treatment of suspected heparin-induced thrombocytopeniaKyle A Davis, Daphne O Davis
Journal of Pharmacy Practice|August 15, 2017
Evaluation of Direct-Acting Oral Anticoagulant Use in Patients With CancerDaphne O Davis, Kyle A Davis
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 29, 2014
Lomitapide: A novel agent for the treatment of homozygous familial hypercholesterolemiaKyle A Davis, Marta A Miyares
P & T : a Peer-Reviewed Journal for Formulary Management|January 7, 2014
Serelaxin, a 'breakthrough' investigational intravenous agent for acute heart failureMarta A Miyares, Kyle A Davis
The Annals of Pharmacotherapy|October 26, 2020
Direct Oral Anticoagulants in Select Patients With Hypercoagulable DisordersSara M Valanejad, Kyle A Davis
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|September 20, 2015
Dual antiplatelet therapy with clopidogrel and aspirin after ischemic stroke: A review of the evidenceKyle A Davis, Marta A Miyares, Eric Dietrich
Journal of Thrombosis and Thrombolysis|January 10, 2020
Direct oral anticoagulants and warfarin in patients with cirrhosis: a comparison of outcomesKyle A Davis, Joel Joseph, Sarah A Nisly
The Annals of Pharmacotherapy|March 7, 2020
Outcomes Associated With Resuming Direct Oral Anticoagulant Therapy Following Admission for a Gastrointestinal BleedSara M Valanejad, Kyle A Davis, Sarah A Nisly
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|February 9, 2022
Adherence to goal-directed therapy for patients with cirrhosis hospitalized with spontaneous bacterial peritonitisChrysten M Eberhard, Kyle A Davis, Sarah A Nisly
Pageof 3